Archives of Medical Research
Volume 41, Issue 3 , Pages 195-200 , April 2010

Expression of Two Testis-specific Genes, SPATA19 and LEMD1, in Prostate Cancer

  • Soudeh Ghafouri-Fard

      Affiliations

    • Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Zahra Ousati Ashtiani

      Affiliations

    • Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Bareto Sabah Golian

      Affiliations

    • Sabah Golian Ultrasound Clinic, Tehran, Iran
    • ,
  • Seyyed-Mohammad Hasheminasab

      Affiliations

    • Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran
    • ,
  • Mohammad Hossein Modarressi

      Affiliations

    • Medical Genetics Department, Tehran University of Medical Sciences, Tehran, Iran
    • Pasteur Institute of Iran, Tehran, Iran
    • Corresponding Author InformationAddress reprint requests to: Mohammad-Hossein Modarressi, Medical Genetics Department, Tehran University of Medical Sciences, Enghelab Street, Tehran, Iran 1417613151; Phone and Fax: 00982188953005

Received 2 January 2010 ,Accepted 30 March 2010.

References 

  1. Kopper L, Timar J. Genomics of prostate cancer: is there anything to “translate”?. Pathol Oncol Res. 2005;11:197–203
  2. Said J. Biomarker discovery in urogenital cancer. Biomarkers. 2005;10:83–86
  3. Ousati Ashtiani Z, Ayati M, Modarresi MH, et al. Association of TGIFLX/Y mRNA expression with prostate cancer. Med Oncol. 2009;26:73–77
  4. Old LJ. Cancer immunology: the search for specificity G.H.A. Clowes Memorial Lecture. Cancer Res. 1981;41:361–375
  5. Boon T, Old LJ. Cancer tumor antigens. Curr Opin Immunol. 1997;9:681–683
  6. Simpson AJC, Caballero OL, Jungbluth A, et al. Cancer/testis antigens, gametogenesis and cancer. Nature Rev/Cancer. 2005;5:615–625
  7. Meklat F, Li Z, Wang Z, et al. Cancer-testis antigens in haematological malignancies. Br J Haematol. 2007;136:769–776
  8. Ghafouri-Fard S, Modarressi MH. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med. 2009;12:395–404
  9. Dave DS, Leppert JT, Rajfer J. Is the testis a chemo-privileged site? Is there a blood-testis barrier?. Rev Urol. 2007;9:28–32
  10. Parmigiani RB, Bettoni F, Grosso DM, et al. Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical recurrence. Int J Cancer. 2008;122:2385–2390
  11. Yokokawa J, Bera TK, Palena C, et al. Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4). Int J Cancer. 2007;121:595–605
  12. Mobasheri MB, Jahanzad I, Mohagheghi MA, et al. Expression of two testis-specific genes, TSGA10 and SYCP3, in different cancers regarding their pathological features. Cancer Detect Prev. 2007;31:296–302
  13. Mobasheri MB, Modarressi MH, Shabani M, et al. Expression of the testis-specific gene, TSGA10, in Iranian patients with acute lymphoblastic leukemia (ALL). Leuk Res. 2006;30:883–889
  14. Ghafouri-Fard S, Abbasi A, Moslehi H, et al. Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol. 2009;[Epub ahead of print]
  15. Kierszenbaum AL. Keratins: unraveling the coordinated construction of scaffolds in spermatogenic cells. Mol Reprod Dev. 2002;61:1–2
  16. Miyamoto T, Sengoku K, Hayashi H, et al. Isolation and expression analysis of the testis-specific gene, human OPPO1. J Assist Reprod Genet. 2004;21:129–134
  17. Kitamura K, Miyagawa Y, Iguchi N, et al. Molecular cloning and characterization of the human orthologue of the oppo 1 gene encoding a sperm tail protein. Mol Hum Reprod. 2003;9:237–243
  18. Fawcett DW. The mammalian spermatozoon. Dev Biol. 1975;44:394–436
  19. Baltz JM, Williams PO, Cone RA. Dense fibers protect mammalian sperm against damage. Biol Reprod. 1990;43:485–491
  20. URL: www.genecards.org. Retrieved February 2010.
  21. Miyamoto T, Sengoku K, Hasuike S, et al. Isolation and expression analysis of the human testis-specific gene, SPERGEN-1, a spermatogenic cell-specific gene-1. J Assist Reprod Genet. 2003;20:101–104
  22. Doiguchi M, Mori T, Toshimori K, et al. Spergen-1 might be an adhesive molecule associated with mitochondria in the middle piece of spermatozoa. Dev Biol. 2002;252:127–137
  23. Yuki D, Lin YM, Fuji Y, et al. Isolation of LEM domain-containing 1, a novel testis-specific gene expressed in colorectal cancers. Oncol Rep. 2004;12:275–280
  24. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol. 2003;62:593–604
  25. Donkor FF, Mönnich M, Czirr E, et al. Outer dense fibre protein 2 (ODF2) is a self-interacting centrosomal protein with affinity for microtubules. J Cell Sci. 2004;117:4643–4651
  26. Gogvadze V, Orrenius S, Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol. 2008;18:165–173

PII: S0188-4409(10)00075-5

doi: 10.1016/j.arcmed.2010.04.003

Archives of Medical Research
Volume 41, Issue 3 , Pages 195-200 , April 2010

Article Tools

* Image Usage & Resolution